The theranostic optimization of PSMA-GCK01 does not compromise the imaging characteristics of [99mTc]Tc-PSMA-GCK01 compared to dedicated diagnostic [99mTc]Tc-EDDA/HYNIC-iPSMA in prostate cancer
Loading...
Date
Authors
Mamlins, Eduards
Scharbert, Lara
Cardinale, Jens
Krotov, Maria
Winter, Erik
Rathke, Hendrik
Strodel, Birgit
Ankrah, Alfred O
Sathekge, Mike Machaba
Haberkorn, Uwe
Journal Title
Journal ISSN
Volume Title
Publisher
Springer
Abstract
Please read abstract in the article.
Description
DATA AVAILABILITY : The data used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Keywords
PSMA-GCK01, Technetium-99 m, Single-photon emission computed tomography (SPECT), Theranostics, Prostate cancer, Prostate-specific membrane antigen (PSMA), SDG-03: Good health and well-being
Sustainable Development Goals
SDG-03:Good heatlh and well-being
Citation
Mamlins, E., Scharbert, L., Cardinale, J. et al. The Theranostic Optimization of PSMA-GCK01 Does Not Compromise the Imaging Characteristics of [99mTc]Tc-PSMA-GCK01 Compared to Dedicated Diagnostic [99mTc]Tc-EDDA/HYNIC-iPSMA in Prostate Cancer. Molecular Imaging and Biology 26, 81–89 (2024). https://doi.org/10.1007/s11307-023-01881-y.